Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Card Fail. 2015 Apr 22;21(6):460–469. doi: 10.1016/j.cardfail.2015.04.005

Table 1.

Baseline Characteristics of the HF and Control Patients*

Variable HF Patients
(N=24)
Control
Patients
(N=10)
P Value
Age, y 65.3±15.0 65.4±13.0 .79
Male sex, 20 (83) 6 (60) .19
CAD 11 (46) 1 (10) .06
Ischemic cardiomyopathy 10 (42) 0 .02
Hypertension 11 (46) 3 (30) .46
Diabetes 9 (38) 1 (10) .21
QRS duration, ms 172±24 103±23 <.001
LVEF, % 23.5±6.3 62.9±3.3 <.001
LVEDD, mm 66.6 ±9.9 48.6±2.7 <.001
ACEI/ARB 16 (67) 0 <.001
β-Blocker 18 (75) 5 (50) .23
Digoxin 7 (29) 0 .08
Statin 14 (58) 0 .002

Abbreviations: ACEI/ARB, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker; CAD, coronary artery disease; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction.

*

Values are number (percentage) or mean±standard error of the mean unless indicated otherwise.